Vivoryon Therapeutics N.V. (LON:0R3M)
1.414
-0.036 (-2.48%)
Feb 12, 2026, 12:21 PM GMT
Vivoryon Therapeutics Employees
Vivoryon Therapeutics had 14 employees as of December 31, 2024. The number of employees decreased by 1 or -6.67% compared to the previous year.
Employees
14
Change (1Y)
-1
Growth (1Y)
-6.67%
Revenue / Employee
n/a
Profits / Employee
-764.25K GBP
Market Cap
36.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 14 | -1 | -6.67% |
| Dec 31, 2023 | 15 | 0 | - |
| Dec 31, 2022 | 15 | 0 | 0.67% |
| Dec 31, 2021 | 15 | -3 | -17.22% |
| Dec 31, 2020 | 18 | 1 | 5.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Kooth | 593 |
| Arecor Therapeutics | 44 |
| Poolbeg Pharma | 16 |
| ImmuPharma | 6 |